文献速递鼻科

局部鼻用减充血剂羟甲唑啉(0.05%)可缓解鼻部症状达12小时

Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours.
PubMed 文献 · Rhinology · 2018-01-01

两项随机双盲、赋形剂对照、单次给药、平行临床研究(研究1 n=67;研究2 n=61)评估0.05%羟甲唑啉鼻喷剂对急性卡他性鼻炎患者的疗效,观察12小时。汇总分析显示,0.05%羟甲唑啉在主观鼻塞和客观鼻通畅度指标上均较基线有统计学显著改善,且改善可持续至12小时;不良事件不常见。

要点

  • 0.05%羟甲唑啉单次给药后主观鼻塞缓解可持续12小时。
  • 客观鼻气流指标在给药后各时间点至12小时均有统计学显著改善。
  • 主观鼻塞评分改善≥1.0分的受试者比例在羟甲唑啉组各时间点均显著高于赋形剂组。

核心结论

  • 0.05%羟甲唑啉单次给药可提供统计学显著且具临床意义的鼻塞缓解并改善鼻气流,效果持续达12小时。

研究设计与样本

  • 两项随机、双盲、赋形剂对照、单次给药、平行临床研究(研究1 n=67;研究2 n=61),在急性卡他性鼻炎患者中评估0.05%羟甲唑啉鼻喷剂12小时内的疗效。

主要发现

  • 汇总分析显示,0.05%羟甲唑啉与赋形剂在每小时时间点(第1小时至第12小时)的主观鼻塞较基线变化均有统计学显著性(第11小时为边缘显著)。
  • 客观鼻气流指标在至12小时的各时间点均有统计学显著性。
  • 两种治疗的不良事件均不常见。
  • 在6点鼻塞量表上,主观鼻塞评分改善至少1.0分的受试者数量在羟甲唑啉组各每小时时间点均显著高于赋形剂组。

临床怎么用

  • 对于急性卡他性鼻炎患者,可考虑使用0.05%羟甲唑啉鼻喷剂单次给药以缓解鼻塞并改善鼻气流,效果可持续12小时。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nasal congestion, often referred to as stuffy nose or blocked nose is one of the most prevalent and bothersome symptoms of an upper respiratory tract infection. Oxymetazoline, a widely used intranasal decongestant, offers fast symptom relief, but little is known about the duration of effect. METHODOLOGY: The results of 2 randomized, double-blind, vehicle-controlled, single-dose, parallel, clinical studies (Study 1, n=67; Study 2, n=61) in which the efficacy of an oxymetazoline (0.05% Oxy) nasal spray in patients with acute coryzal rhinitis was assessed over a 12-hour time-period. Data were collected on both subjective relief of nasal congestion (6-point nasal congestion scale) and objective measures of nasal patency (anterior rhinomanometry) in both studies. RESULTS: A pooled study analysis showed statistically significant changes from baseline in subjective nasal congestion for 0.05% oxymetazoline and vehicle at each hourly time-point from Hour 1 through Hour 12 (marginally significant at Hour 11). An objective measure of nasal flow was statistically significant at each time-point up to 12 hours. Adverse events on either treatment were infrequent. The number of subjects who achieved an improvement in subjective nasal congestion scores of at least 1.0 was significantly higher in the Oxy group vs. vehicle at all hourly time-points on a 6-point nasal congestion scale. CONCLUSIONS: This study shows for the first time, that oxymetazoline provides both statistically significant and clinically meaningful relief of nasal congestion and improves nasal airflow for up to 12 hours following a single dose.

来源:Rhinology,查看原文。版权归原作者所有。

引用

  1. Druce HM, Ramsey DL, Karnati S, et al. Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours. Rhinology. 2018. PMID: 29785414. doi:10.4193/Rhin17.150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。